1 Min Read
April 26 (Reuters) - Kiadis Pharma NV:
* Kiadis Pharma announces filing of marketing authorization with the European Medicines Agency for Atir101™ in blood cancers Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.